The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremia

IntroductionInfective endocarditis (IE) is a common complication of Staphylococcus aureus bacteremia (SAB). The study aimed to develop and validate a prediction score to determine IE risk among SAB.MethodsThis retrospective study included adults with SAB (2015–2021) and divided them into derivation...

Full description

Bibliographic Details
Main Authors: Matthaios Papadimitriou-Olivgeris, Pierre Monney, Linda Mueller, Laurence Senn, Benoit Guery
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.961579/full
_version_ 1811159341689995264
author Matthaios Papadimitriou-Olivgeris
Matthaios Papadimitriou-Olivgeris
Pierre Monney
Linda Mueller
Laurence Senn
Laurence Senn
Benoit Guery
author_facet Matthaios Papadimitriou-Olivgeris
Matthaios Papadimitriou-Olivgeris
Pierre Monney
Linda Mueller
Laurence Senn
Laurence Senn
Benoit Guery
author_sort Matthaios Papadimitriou-Olivgeris
collection DOAJ
description IntroductionInfective endocarditis (IE) is a common complication of Staphylococcus aureus bacteremia (SAB). The study aimed to develop and validate a prediction score to determine IE risk among SAB.MethodsThis retrospective study included adults with SAB (2015–2021) and divided them into derivation and validation cohorts. Using the modified 2015 European Society of Cardiology modified Duke Criteria for definite IE, the LAUSTAPHEN score was compared to previous scores.ResultsAmong 821 SAB episodes, 419 and 402 were divided into derivation and validation cohorts, respectively. Transthoracic and transoesophageal echocardiography (TOE) were performed in 77.5 and 42.1% of episodes, respectively. Definite IE was diagnosed in 118 episodes (14.4%). Derivation cohort established that cardiac predisposing factors, such as cardiac implantable electronic devices, prolonged bacteremia ≥48 h, and vascular phenomena were independently associated with IE. In addition to those parameters, native bone and joint infections were used to constitute the LAUSTAPHEN score. LAUSTAPHEN and VIRSTA scores misclassified <4% of IE cases as low risk. Misclassification using POSITIVE and PREDICT scores was >10%. The number of TOEs required to safely exclude IE were 66.9 and 51.6% with VIRSTA and LAUSTAPHEN, respectively.DiscussionLAUSTAPHEN and VIRSTA scores exhibited the lowest misclassification rate of IE cases to the low-risk group. However, the number of patients requiring TOE was higher for VIRSTA than for LAUSTAPHEN.
first_indexed 2024-04-10T05:40:32Z
format Article
id doaj.art-f5aad055305446a3aa57f72524ca99a7
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-10T05:40:32Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-f5aad055305446a3aa57f72524ca99a72023-03-06T11:51:08ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-12-01910.3389/fcvm.2022.961579961579The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremiaMatthaios Papadimitriou-Olivgeris0Matthaios Papadimitriou-Olivgeris1Pierre Monney2Linda Mueller3Laurence Senn4Laurence Senn5Benoit Guery6Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, SwitzerlandInfection Prevention and Control Unit, Lausanne University Hospital and University of Lausanne, Lausanne, SwitzerlandDepartment of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, SwitzerlandInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, SwitzerlandInfectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, SwitzerlandInfection Prevention and Control Unit, Lausanne University Hospital and University of Lausanne, Lausanne, SwitzerlandInfectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, SwitzerlandIntroductionInfective endocarditis (IE) is a common complication of Staphylococcus aureus bacteremia (SAB). The study aimed to develop and validate a prediction score to determine IE risk among SAB.MethodsThis retrospective study included adults with SAB (2015–2021) and divided them into derivation and validation cohorts. Using the modified 2015 European Society of Cardiology modified Duke Criteria for definite IE, the LAUSTAPHEN score was compared to previous scores.ResultsAmong 821 SAB episodes, 419 and 402 were divided into derivation and validation cohorts, respectively. Transthoracic and transoesophageal echocardiography (TOE) were performed in 77.5 and 42.1% of episodes, respectively. Definite IE was diagnosed in 118 episodes (14.4%). Derivation cohort established that cardiac predisposing factors, such as cardiac implantable electronic devices, prolonged bacteremia ≥48 h, and vascular phenomena were independently associated with IE. In addition to those parameters, native bone and joint infections were used to constitute the LAUSTAPHEN score. LAUSTAPHEN and VIRSTA scores misclassified <4% of IE cases as low risk. Misclassification using POSITIVE and PREDICT scores was >10%. The number of TOEs required to safely exclude IE were 66.9 and 51.6% with VIRSTA and LAUSTAPHEN, respectively.DiscussionLAUSTAPHEN and VIRSTA scores exhibited the lowest misclassification rate of IE cases to the low-risk group. However, the number of patients requiring TOE was higher for VIRSTA than for LAUSTAPHEN.https://www.frontiersin.org/articles/10.3389/fcvm.2022.961579/fullStaphylococcus aureus bacteraemiainfective endocarditistransoesophageal echocardiography (TOE)bloodstream infectionrisk stratification
spellingShingle Matthaios Papadimitriou-Olivgeris
Matthaios Papadimitriou-Olivgeris
Pierre Monney
Linda Mueller
Laurence Senn
Laurence Senn
Benoit Guery
The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremia
Frontiers in Cardiovascular Medicine
Staphylococcus aureus bacteraemia
infective endocarditis
transoesophageal echocardiography (TOE)
bloodstream infection
risk stratification
title The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremia
title_full The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremia
title_fullStr The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremia
title_full_unstemmed The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremia
title_short The LAUsanne STAPHylococcus aureus ENdocarditis (LAUSTAPHEN) score: A prediction score to estimate initial risk for infective endocarditis in patients with S. aureus bacteremia
title_sort lausanne staphylococcus aureus endocarditis laustaphen score a prediction score to estimate initial risk for infective endocarditis in patients with s aureus bacteremia
topic Staphylococcus aureus bacteraemia
infective endocarditis
transoesophageal echocardiography (TOE)
bloodstream infection
risk stratification
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.961579/full
work_keys_str_mv AT matthaiospapadimitriouolivgeris thelausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT matthaiospapadimitriouolivgeris thelausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT pierremonney thelausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT lindamueller thelausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT laurencesenn thelausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT laurencesenn thelausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT benoitguery thelausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT matthaiospapadimitriouolivgeris lausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT matthaiospapadimitriouolivgeris lausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT pierremonney lausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT lindamueller lausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT laurencesenn lausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT laurencesenn lausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia
AT benoitguery lausannestaphylococcusaureusendocarditislaustaphenscoreapredictionscoretoestimateinitialriskforinfectiveendocarditisinpatientswithsaureusbacteremia